High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn’s Disease
Ebach, Dawn R. MD; Jester, Traci W. MD, RD; Galanko, Joseph A. PhD; Firestine, Ann M. MS; Ammoury, Rana MD; Cabrera, Jose MD; Bass, Julie MD; Minar, Phillip MD; Olano, Kelly BA, BS; Margolis, Peter MD, PhD; Sandberg, Kelly MD, MSc; Linnville, Tiffany M. MD; Kaplan, Jess MD; Pitch, Lisa MA; Steiner, Steven J. MD; Bass, Dorsey MD; Moses, Jonathan MD; Adler, Jeremy MD; Gulati, Ajay S. MD; Wali, Prateek MD; Pashankar, Dinesh MD; Ivanova, Anastasia PhD; Herfarth, Hans MD, PhD; Wohl, David A. MD; Benkov, Keith J. MD; Strople, Jennifer MD, MS; Sullivan, Jillian MD, MSc; Tung, Jeanne MD; Molle-Rios, Zorela MD; Saeed, Shehzad A. MD; Bousvaros, Athos MD, MPH, FACG; Kappelman, Michael D. MD, MPH, FACG.
March 2024
Comparison of Paediatric Patients and Young Adults with Moderately to Severely Active Crohn’s Disease Treated with Ustekinumab in the REALITI Real-World Evidence Effectiveness Study
S Steiner, S Shehzad, J Adler, R B Colletti, R Strauss, J Heile, O Adedokun, A Sheahan, R Zhang, K H Lo, L Kim, Y Xiao, S Volger
January 2024
Comparison of all paediatric patients and young adults with Crohn’s Disease treated with ustekinumab in the REALITI Real-World Evidence Effectiveness Study
S Shehzad, S Steiner, J Adler, R B Colletti, R Strauss, J Heile, O Adedokun, A Sheahan, R Zhang, K H Lo, L Kim, Y Xiao, S Volger
January 2024
The Effect of Ustekinumab on Mucosal Inflammation in Paediatric Crohn’s Disease: The REALITI Real-World Evidence Effectiveness Study
J Adler, S Steiner, S Saeed, R Colletti, R Strauss, B Godwin, A Sheahan, R Zhang, L Kim, Y Xiao, S Volger
January 2024
Surveying outcomes of service user experience on the effects of emotional well-being and schooling in paediatric IBD (PIBD) patients in a tertiary PIBD centre
C Lashley, R Buckingham, B Huggett, T Sawney, S Chadokufa, F Kiparissi, A Elzein
January 2024
Surveying outcomes of service user experience on the effects of the transition process in paediatric IBD (PIBD) patients in a tertiary PIBD centre
R Buckingham, S Chadokufa, C Lashley, B Huggett, T Sawney, F Kiparissi, A Elzien Catherine Lashley Sibongile Chadokufa Bonita Huggett Terry Sawney Fevronia Kiparissi Aya Elzein
January 2024
A Mixed Methods Exploration of Diversity, Equity, and Inclusion (DEI) Care Processes Within a Pediatric IBD Learning Health Network
Parakala, Mahalakshmi; Kim, Sandra; David, Jennie; Pitch, Lisa
A-LiNK: Prospective Outcomes of Pediatric Autoimmune Liver Disease in a Learning Health Network.
Amy Taylor, Cyd Castro-Rojas, Mosab Alquraish, Sakil Kulkarni, Janis Stoll, Mary Ayers, Zachariah Shalginewicz, Katelyn Saarela, Shehzad Saeed, Alexander Miethke, James Squires
Assessing Acceptance Among Young People with Inflammatory Bowel Disease: Development of the Inflammatory Bowel Disease Acceptance Questionnaire for Adolescents and Young Adults.
Anava Wren, Nicole Neiman, Rachel Bensen, Ann Ming Yeh, Laurie Keefer
Impact of Immunomodulator Withdrawal From Anti-TNF Therapy in Pediatric Patients with Crohn's Disease.
Anita Sharma, Jana Creps, Lauren Manning, Michaella Baker, Sabina Ali, Jonathan Moses, Brad Pasternak, David Suskind, Charles Samson, Jess Kaplan, Jeremy Adler
Exploring Health Mindset in Adolescents and Young Adults with Inflammatory Bowel Disease: Relationship Between Health Mindset and Psychosocial Outcomes.
Claudia Mueller, Nicole Neiman, Rachel Bensen, Ann Ming Yeh, Anava Wren
Effect of Proactive Therapeutic Drug Monitoring on Discontinuation of Anti-TNF Medications For Pediatric Patients with Crohn's Disease.
Jonathan Moses, Sabina Ali, Brad Pasternak, David Suskind, Charles Samson, Jess Kaplan, Jeremy Adler
Aminosalicylate Use in Pediatric Patients with Crohn's Disease.
Perseus Patel, Jess Kaplan, Jonathan Moses, Brad Pasternak, Charles Samson, David Suskind, Sabina Ali, Jeremy Adler
Therapeutic Drug Monitoring Practices, Barriers and Attitudes Among a Nationwide Learning Health System for IBD.
Ruben Colman, Jennifer Dotson, Kelly Sandberg, Shehzad Saeed, Peter Margolis, Jasbir Dhaliwal
Effects of Pre-Existing Atopy on Biologic Use Patterns in Crohn's Disease.
Archana Anandakrishnan, Jeremy Adler, Sabina Ali , Jess Kaplan, Jonathan Moses, Charles Samson, David Suskind, Brad Pasternak
High Out of Pocket Costs for Infliximab Infusions are Associated with Disease Activity in Pediatric Inflammatory Bowel Disease.
Christopher Moran, Jill Horan, Molly McGoldrick, Esther Israel
A Mixed Methods Exploration of Diversity, Equity, and Inclusion (DEI) Care Processes Within a Pediatric IBD Learning Health Network.
Parakala, Mahalakshmi; Kim, Sandra; David, Jennie; Pitch, Lisa
Using a Real Time Dashboard to Support Population Health in Inflammatory Bowel Disease.
Robert Lloyd, Leenoy Zaarur, Briana Procopio, Lisa McMahon, Christina Rodriguez, Vinay Vaidya, McCalley Steve, Pierina Ortiz, Ashish Patel, Jamie Smith, Brad Pasternak
Multidisciplinary Management, Anti-TNF Therapy, and Clinical Outcomes of Internally Penetrating Crohn's Disease Complication in Pediatrics: Interim Analyses of a Multicenter Retrospective Cohort.
Brad Constant, Janet Okraku-Mantey, Kelly Kachelries, Sudha Anupindi, Jing Huang, Robert Baldassano, Frank Scott, Edwin de Zoeten, Ryan Morrow, Sabina Ali, Becca Trombler, Brad Pasternak, Amanda Kuehn, Jacob Kurowski, Jessica Barry, Jeremy Adler, Ibrahim Tarabishy, Whitney Sunseri, Erin Crawford, Jennifer Dotson, Shervin Rabizadeh, David Ziring, Jeannie Huang, Rusvelda Cruz, Cary Sauer, Lindsey Albenberg
Understanding Pediatric GI Providers' Perceptions of and Engagement with Psychosocial Providers in Pediatric IBD Care
Jennie David, Ellen Sejkora, Hilary Michel, Laura Mackner
Multicenter Evaluation of Patterns of and Reasons for Biologic Medication Discontinuation Among Children with Crohn's Disease
Jeremy Adler, Jana Creps, Dianne Singer, Michaella Baker, Sabina Ali, Archana Anandakrishnan, Madeline Ford, Joanne Ginley, Jess Kaplan, Jonathan Moses, Charles Samson, David Suskind, Becca Trombler, Brad Pasternak
Disparities in Height at the Time of Inflammatory Bowel Disease Diagnosis
Joann Samalik, Jeremy Adler
Autoimmune Liver Disease Network for Kids (A-LiNK): Building a Learning Health Network within ImproveCareNow
Amy Taylor, James Squires, Cyd Castro Rojas, Shehzad Saeed, Kristin Howe, Mary Bauer, Lauren McClain, Mallory Moor, Jane Weyer, Christine Browner, Nicole Weyer, Fionna Kopp, Alexander Weymann, Sakil Kulkarni, Emily Perito, Heli Bhatt, Gillian Noel, Evelyn Hsu, Katelyn Saarela, Nitika Gupta, Leina Alrabadi, Mary Ayers, Mosab Alquraish, Saeed Mohammad, Peter Margolis, Alexander Miethke
Comparative Effectiveness of Ustekinumab Versus Vedolizumab in Tumor Necrosis Factor Inhibitor-Exposed Pediatric Patients with Ulcerative Colitis
Perseus Patel, Balu Bhasuran, Sofia Verstraete, Melvin Heyman, Atul Butte, Vivek Rudrapatna
Factors Impacting Pediatric Gastroenterologists Approach to Biosimilar Utilization in Inflammatory Bowel Disease Care
Ross Maltz, Madeline McClinchie, Brendan Boyle, Megan McNicol, Grant Morris, Erin Crawford, Jonathan Moses, Sandra Kim
Feasibility of Using Real-World Data from the ImproveCareNow Registry to Examine the Efficacy of Ustekinumab for Pediatric Crohn's Disease
Steven Steiner, Richard Strauss, Richard Colletti, Eileen King, Shiran Chen, Kelly Olano, Robert Baldassano, Stanley Cohen, Michael Kappelman, Shehzad Saeed, Yiting Wang, Sheri Volger
Fear of the COVID-19 Pandemic in Adolescents and Young Adults with Inflammatory Bowel Disease: Relationship to Psychological and Physical Outcomes
Nicole Neiman, Kavya Anjur, Ann Ming Yeh, Rachel Bensen, Anava Wren
Enteral Nutrition as Primary Therapy of Pediatric Inflammatory Bowel Disease in the USA
Amer Sajed, Shehzad Saeed, Richard B. Colletti, Gigi Veereman
Changing Use of Biologic Medications and Associated Outcomes for Pediatric Inflammatory Bowel Disease
Jeremy Adler, MD
Predictors of Treatment Completion in Online Mindfulness-Based Interventions for Well-Being
French, N. J., Stromberg, A. R., Albury E. A., Stephan, N. J., George, N., Shannon, A. P., Yu, C., Rabideau, D. J., Pitch, L., Lunn, M. R., Obedin-Maliver, J., Sylvia, L. G., & Nierenberg, A. A.
Self-Compassion in Adolescents and Young Adults with Inflammatory Bowel Disease: Relationship of Self-Compassion to Psychological and Physical Outcomes
Nicole Neiman, Ann Ming Yeh, Rachel Bensen, Elvi Sanjines, Anava Wren, SELF-COMPASSION IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE: RELATIONSHIP OF SELF-COMPASSION TO PSYCHOLOGICAL AND PHYSICAL OUTCOMES, Gastroenterology, Volume 160, Issue 3, Supplement, 2021, Pages S74-S75, ISSN 0016-5085, https://doi.org/10.1053/j.gastro.2021.01.181.
African American Race is Associated with Lower Health Literacy Among Caregivers of Children with Inflammatory Bowel Disease
Tiffany Linville, Emmala Waduge, Jeremy Adler, Sabina Ali, Rana Ammoury, Colleen Brensinger, Jose Cabrera, Ryan Cox, J. del Rosario, Jill Dorsey, Jennifer Dotson, Matthew Egberg, Mel Hyman, Tracy Jester, Subra Kugathasan, Ian Leibowitz, Maureen Mccauley, Zarela Molle Rios, Yuliya Rekhtman, Chip Samson, Kelly Sandberg, Jen Savas, Shehzad Saeed, Jennifer Strople, Jeanne Tung, Sofia Verstraete, James Lewis, Michael Kappelman
Risk Factors Associated with Severe Colitis and Colectomy in Pediatric Ulcerative Colitis: Results from the ImproveCareNow Network
Karine Amirikian, Jaeun Choi, Xianhong Xie, Mimi Kim, Gitit Tomer
Provider Practices in Management of Obesity in Patients with Pediatric Inflammatory Bowel Disease
Namrata Patel, Sofia Verstraete, Jennifer Burgis, Carly Isman, Luis Rodriguez, Emily Stekol, Sabina Ali
Approaching Obesity in Pediatric Inflammatory Bowel Disease: A Quality Improvement Initiative
Namrata Patel, Sabina Ali, Jennifer Burgis, Emily Stekol, Carly Isman, Luis Rodriguez, Sofia Verstraete
Depression screening in a pediatric IBD center
Talmadge C, Lewis G, Gold B, Gomez S, Reed B, Dykes D. Depression screening in a pediatric IBD center. Inflammatory Bowel Disease 26 2020;(S1): S62-63
Understanding Real-World Biologic Maintenance Dosing Patterns among Pediatric Ulcerative Colitis and Crohn’s Disease Patients
Crandall, W., Colletti, R., Komocsar W., Liu, C., Dotson, J., Benkov, K., Steiner, S., Zhang, N., Theresa Hunter. (November 1-7, 2020) Understanding Real-World Biologic Maintenance Dosing Patterns among Pediatric Ulcerative Colitis and Crohn’s Disease Patients. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Annual Meeting. Virtual.
Treatment Patterns of Newly Diagnosed Pediatric Ulcerative Colitis and Crohn’s Disease Patients in the ImproveCareNow Registry
Hunter T., Komocsar W., Colletti R., Liu C., Benkov, K., Dotson, J., Steiner, S., Zhang N., Crandall, W (November 1-7, 2020) Treatment Patterns of Newly Diagnosed Pediatric Ulcerative Colitis and Crohn’s Disease Patients in the ImproveCareNow Registry. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Annual Meeting. Virtual.
Disease Activity, Steroid-free Remission, and Clinical Outcome Assessments of Pediatric Ulcerative Colitis and Crohn’s Disease Patients Receiving Biologic Therapy
Theresa Hunter, Komocsar, W., Liu, C., Colletti, R., Steiner, S., Dotson, J., Benkov, K., Zhang, N., Crandall, W. (November 1-7, 2020) Disease Activity, Steroid-free Remission, and Clinical Outcome Assessments of Pediatric Ulcerative Colitis and Crohn’s Disease Patients Receiving Biologic Therapy. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Annual Meeting. Virtual.
Trajectory, risk factors, and impact of abdominal pain during the first year after pediatric IBD diagnosis: Results from the ImproveCareNow Network
Murphy L, Gashi K, Kawamura J, Zhou C, Lynch D, Suskind D, Palermo T. Trajectory, risk factors, and impact of abdominal pain during the first year after pediatric IBD diagnosis: Results from the ImproveCareNow Network. J Pediatr Gastroenterol Nutr 69 2019;(S1): S95-96
Reduction in corticosteroid usage among pediatric patients with inflammatory bowel disease in a large learning health system
Kandavel P, Adler J, Meister S. Reduction in corticosteroid usage among pediatric patients with inflammatory bowel disease in a large learning health system. J Pediatr Gastroenterol Nutr 69 2019;(S1): S232-233
Insurance status but not race determines sustained remission in pediatric IBD
Doan S, Jofriet A, Scott O, Riswan A, Venkateswaran S, Somineni H, Niklinska-Schirtz B, Talmadge C, Fritzen C, Dinser M, Dykes D, Gold B, Sauer C, Kugathasan S, Schoen B. Insurance status but not race determines sustained remission in pediatric IBD. J Pediatr Gastroenterol Nutr 69 2019;(S1): S80-81
Anemia prevalence in pediatrics IBD: Still persisted after 1 year
Malik P, Kim M, Puopolo G, Thompson J, Tomer G. Anemia prevalence in pediatrics IBD: Still persisted after 1 year. J Pediatr Gastroenterol Nutr 69 2019;(S1): S244-245
Hospitalizations in children with inflammatory bowel disease
Alper A, Algara M, Phatak U, Pashankar D. Hospitalizations in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 69 2019;(S1): S64-65
Treatment of pediatric Crohn's disease patients with early perianal complications
Adler J, Gadepalli S, Zacur G, Jarboe M, Dombkowski K. Treatment of pediatric Crohn's disease patients with early perianal complications. Inflamm Bowel Dis 24 2018;(S1): S79
"A Guide to Gutsy Living": Patient Driven Development of a Pediatric Ostomy Toolkit
David J, Jofriet A, Seid M, Margolis PA. "A Guide to Gutsy Living": Patient Driven Development of a Pediatric Ostomy Toolkit. Pediatrics 2018;141(5): e20172789
Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure
Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. Gastroenterology 154 2018;(6): S670
Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. Gastroenterology 154 2018;(6): S669-670
Evaluation of adalimumab effectiveness in pediatric patients with ulcerative colitis in clinical practice
Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R, ImproveCareNow Network. Evaluation of adalimumab effectiveness in pediatric patients with ulcerative colitis in clinical practice. Gastroenterology 154 2018;(6): S668-669
Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. Gastroenterology 154 2018;(6): S669
Uveitis in a multicenter pediatric inflammatory bowel disease population: results from the Improvecarenow Network
Schaefer M, Nelson A, Sanchez R. Uveitis in a multicenter pediatric inflammatory bowel disease population: results from the Improvecarenow Network. Gastroenterology 154 2018;(6): S669
Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice
Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R, ImproveCareNow Network. Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice. J Pediatr Gastroenterol Nutr 66 2018;(2): S41
Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure
Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. J Pediatr Gastroenterol Nutr 66 2018;(2): S563
Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. J Pediatr Gastroenterol Nutr 66 2018;(2): S84
Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. J Pediatr Gastroenterol Nutr 66 2018;(2): S96
Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry
Hensel K, Cunion D, Gasparetto M, Brennan M, Folan A, Lee C, Torrente F, Zilbauer M, Heuschkel R. Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry. J Pediatr Gastroenterol Nutr 66 2018;(2): S59
Use of cannabis and opiates by adolescents and young adults with inflammatory bowel disease
Hoffenberg E, Murphy B, Mikulich-Gilbertson S, McWilliams S, Hoffenberg A, Hopfer C. Use of cannabis and opiates by adolescents and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 67 2018;(S1): S62-63
Outcomes in pediatric IBD patients not receiving immunological therapies
Benkov KJ, Serphos D. Outcomes in pediatric IBD patients not receiving immunological therapies. J Pediatr Gastroenterol Nutr 67 2018;(S1): S191-192
Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure
Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. J Pediatr Gastroenterol Nutr 67 2018;(S1): S264-265
Implementing transition of care and transfer of care systems in pediatric IBD
Schaefer M, Tung J, Maddux M, Kim S (2017). Implementing transition of care and transfer of care systems in pediatric IBD. Inflamm Bowel Dis 2017;S73
Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice
Steiner S, King E, Park KT, Pashankar D, Shashidhar H, Sudel B, Eichner S, Chen S, Pratt J, Colletti R . Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice. Gastroenterol 2017;64:S70
Outcomes from patient pre-visit planning (PVP) in Pediatric Inflammatory Bowel Disease (PIBD) using the ImproveCareNow (ICN) tool
Chadokufa S, Wearon R. Outcomes from patient pre-visit planning (PVP) in Pediatric Inflammatory Bowel Disease (PIBD) using the ImproveCareNow (ICN) tool. J Pediatr Gastroenterol Nutr 2017;65(S1): S6
Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice
Steiner S, King E, Park KT, Pashankar D, Shashidhar H, Sudel B, Eichner S, Chen S, Pratt J, Colletti R. Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice. J Pediatr Gastroenterol Nutr 2017;65(S1):S50
Successful use of the ImproveCareNow (ICN) quality improvement tool: Our 7-year outcomes and achievements
Chadokufa S, Acton N, Sider S, Sheppard R, Wearon R, Shah N, Knaflez D, Kiparissi F. Successful use of the ImproveCareNow (ICN) quality improvement tool: Our 7-year outcomes and achievements. J Pediatr Gastroenterol Nutr 2017;65(S1): S196-203
Racial differences in initial presentation, early treatment, and 1-year outcomes of pediatric Crohn's disease: results from the ImproveCareNow network
Dotson JL, Cho M, Bricker J, Kappelman M, Chisolm D, Tomer G, Crandall W. Racial differences in initial presentation, early treatment, and 1-year outcomes of pediatric Crohn's disease: results from the ImproveCareNow network. Inflamm Bowel Dis 2016;22:doi: 10.1097/01
Feasibility of a mobile personalized learning system for assessing daily IBD symptoms and quality of life
Adler J, Saeed S, Thakkar S, Eslick I, Margolis P, Provost L, Kaplan H. Feasibility of a mobile personalized learning system for assessing daily IBD symptoms and quality of life. Inflamm Bowel Dis 2016;22:doi: 10.1097/01
The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn's disease
Benkov JK, Russell GH, Samson C, Steiner S, King E, Pratt J, Eichner S, Colletti RB. The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn's disease. Gastroenterol 2016;150(4):S588
The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn's disease
Benkov JK, Russell GH, Samson C, Steiner S, King E, Pratt J, Eichner S, Colletti RB. The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn's disease. J Pediatr Gastro Nutr 2016;62:77
Prevention of perianal disease among pediatric patients with Crohn's disease in a pediatric inflammatory bowel disease quality improvement collaborative
Adler J, Dong S, Dombkowski K. Prevention of perianal disease among pediatric patients with Crohn's disease in a pediatric inflammatory bowel disease quality improvement collaborative. J of Pediatr Gastro 2016;63:S364
Efficacy and safety of co-therapy of biologics and methotrexate in a pediatric inflammatory bowel disease (pIBD) cohort: a single centre experience
Lozinsky A, Kiparissi F, Huggett B, Chadokufa S, Sider S, Acton N, Baycheva M, Shah N. Efficacy and safety of co-therapy of biologics and methotrexate in a pediatric inflammatory bowel disease (pIBD) cohort: a single centre experience. J of Pediatr Gastro 2016;63(S2):S210-211
Identifying fistulizing Crohn's disease in a national pediatric inflammatory bowel disease quality improvement collaborative registry
Adler J, Dong S, Dombkowski K. Identifying fistulizing Crohn's disease in a national pediatric inflammatory bowel disease quality improvement collaborative registry. Gastroenterol 2015;148:S379
Racial differences in initial presentation and early treatment of pediatric Crohn's disease - preliminary results from the ImproveCareNow Network
Dotson J, Cho M, Bricker J, Kappelman M, Chisolm D, Tomer G, Crandall W. Racial differences in initial presentation and early treatment of pediatric Crohn's disease - preliminary results from the ImproveCareNow Network. Gastroenterol 2015;148:S71
Extent of disease in ulcerative colitis in a pediatric inflammatory bowel disease learning health network
Adler J, Grossman A, Israel EJ, Kim S, Saeed SA, Pratt JM, Collins J, Colletti RB, ImproveCareNow Network. Extent of disease in ulcerative colitis in a pediatric inflammatory bowel disease learning health network. J Pediatr Gastro Nutr 2015;61:S87
Real-world clinical and comparative effectiveness of infliximab in pediatric Crohn’s disease
Kappelman MD, Bailey LC, Crandall WV, Zhang P, King E, Joffe M, Colletti RB, Forrest, CB and the ImproveCareNow Network. Kappelman MD, Bailey LC, Crandall WV, Zhang P, King E, Joffe M, Colletti RB, Forrest, CB and the ImproveCareNow Network. Real-world clinical and comparative effectiveness of infliximab in pediatric Crohn’s disease. Gastroenterol 2013;144:S146
Use of the emergency department in pediatric inflammatory bowel disease
Hoffenberg EJ, Fridge J, Leibowitz I, Tsou M, Dykes D, Kappelman M, Colletti R. Use of the emergency department in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013;57 (suppl 1):e63
Feasibility and validity of the pediatric ulcerative colitis activity index in real-world clinical practice
Dotson JL, Crandall WV, Zhang P, Forrest CB, Bailey LC, Colletti RB, Kappelman MD. Feasibility and validity of the pediatric ulcerative colitis activity index in real-world clinical practice. Inflamm Bowel Dis 2013
Is there seasonal variation of disease activity in pediatric-onset inflammatory bowel disease?
Burkam J, Kappelman M, King E, Pratt J, Colletti R, Bistrick S, Crandall W. Is there seasonal variation of disease activity in pediatric-onset inflammatory bowel disease? Gastroenterol 2012;142:S209
Are there gender differences in the clinical outcomes of pediatric inflammatory bowel disease?
Lee G, Kappelman MD, Boyle B, Colletti R, King E, Pratt J, Crandall W. Are there gender differences in the clinical outcomes of pediatric inflammatory bowel disease? Gastroenterol 2011;140:S196
Increased remission in a quality improvement collaborative for pediatric Crohn disease
Crandall W, Kappelman M, Colletti RB, Denson L, Duffy L, Grunow J, Kim S, Leibowitz I, Patel A, Schoen B, Tomer G, Milov D, Cohen S, Margolis P, and the ImproveCareNow Collaborative (formerly PIBDNet). Increased remission in a quality improvement collaborative for pediatric Crohn disease. Gastroenterol 2010;138:S29
Increased remission in a quality improvement collaborative for pediatric Crohn disease
Crandall W, Kappelman M, Colletti RB, Denson L, Duffy L, Grunow J, Kim S, Leibowitz I, Patel A, Schoen B, Tomer G, Milov D, Cohen S, Margolis P, and the ImproveCareNow Collaborative (formerly PIBDNet). Increased remission in a quality improvement collaborative for pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2009;48:e
A rapid pediatric Crohn's disease activity index for quality improvement and observational research
Kappelman, M, Goudie, A. Crandall, W, Larry, E, Fairbrother, G, Margolis, P, Leibowitz, I, Duffy, L, Milov, D, Kim, S, Schoen, B, Cohen, S, Patel, A, Grunow, J, Colletti, R, and the ImproveCareNow Collaborative (formerly PIBDNet). A rapid pediatric Crohn's disease activity index for quality improvement and observational research. J Pediatr Gastroenterol Nutr 2009;48:e
Increased remission in a quality improvement collaborative for pediatric Crohn disease
Crandall W, Kappelman M, Colletti RB, Denson L, Duffy L, Grunow J, Kim S, Leibowitz I, Patel A, Schoen B, Tomer G, Milov D, Cohen S, Margolis P, and the ImproveCareNow Collaborative (formerly PIBDNet). Increased remission in a quality improvement collaborative for pediatric Crohn disease. Inflamm Bowel Dis 2009;15:s3
A rapid pediatric Crohn's disease activity index for quality improvement and observational research
Kappelman, M, Goudie, A. Crandall, W, Larry, E, Fairbrother, G, Margolis, P, Leibowitz, I, Duffy, L, Milov, D, Kim, S, Schoen, B, Cohen, S, Patel, A, Grunow, J, Colletti, R, and the ImproveCareNow Collaborative (formerly PIBDNet). A rapid pediatric Crohn's disease activity index for quality improvement and observational research. Inflamm Bowel Dis 2009;15:s18
Accelerating improvement in the management of pediatric inflammatory bowel disease
Kappelman MD, Cohen SA, Crandall W, Duffy LF, Gold BD, Grunow J, Kim SC, Leibowitz I, Margolis P, Mehta DI, Milov DE, Moyer MS, Myers SK, Patel AS, Schoen BT, Sudel B, Colletti RB. Accelerating improvement in the management of pediatric inflammatory bowel disease. Gastroenterol 2008;134(S1):A473
Growth failure in a pediatric inflammatory bowel disease registry (PIBDNet) with specific association to disease phenotype
Patel AS, Kim S, Kappelman M, Colletti R, Cohen S, Grunow J, Crandall W, Duffy L, Gold B, Leibowitz I, Margolis P, Mehta D, Milov D, Moyer S, Myers S, Schoen B, Sudel B, Bornstein J. Growth failure in a pediatric inflammatory bowel disease registry (PIBDNet) with specific association to disease phenotype. J Pediatr Gastroenterol Nutr 2008;47:e
The quality of care in pediatric inflammatory bowel disease: does the chronic care model work?
Kappelman M, Margolis P, Moyer M, Cohen S, Gold B, Crandall W, Patel A, Mehta D, Milov D, Grunow J, Leibowitz I, Colletti R. The quality of care in pediatric inflammatory bowel disease: does the chronic care model work? J Pediatr Gastroenterol Nutr 2007;45:e5
Variation in initial 6-mercaptopurine dosage in pediatric Crohn's disease
Colletti RB, Baldassano RN, Milov DE, Margolis PA, PIBDNet –the Pediatric IBD Network for Research and Improvement. Variation in initial 6-mercaptopurine dosage in pediatric Crohn's disease. Gastroenterol 2006;130:A652
Predictors of outcome of treatment of pediatric Crohn’s disease with 6-mercaptopurine or azathioprine
Colletti RB, Baldassano RN, Milov DE, for PIBDNet—the Pediatric IBD Network for Research and Improvement. Predictors of outcome of treatment of pediatric Crohn’s disease with 6-mercaptopurine or azathioprine. J Pediatr Gastroenterol 2006;43(supp2):S40
Initial dosage of 6-mercaptopurine in pediatric Crohn’s disease: a study of variation in care
Colletti RB, Baldassano RN, Milov DE, for PIBDNet—the Pediatric IBD Network for Research and Improvement. Initial dosage of 6-mercaptopurine in pediatric Crohn’s disease: a study of variation in care. J Pediatr Gastroenterol 2006;43(supp2):S41
PIBDNet—the Pediatric IBD Network for Research and Improvement
Milov D, Baldassano R, Colletti R, Margolis P, for PIBDNet—the Pediatric IBD Network for Research and Improvement. PIBDNet—the Pediatric IBD Network for Research and Improvement. J Pediatr Gastroenterol Nutr 2005;41:536
Variation in initial evaluation and treatment of pediatric Crohn disease
Colletti R, Baldassano R, Milov D, Margolis P, for PIBDNet—the Pediatric IBD Network for Research and Improvement. Variation in initial evaluation and treatment of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2005;41:537
Variation in initial 6-mercaptopurine dosage in Crohn disease
Baldassano R, Colletti R, Milov D, Margolis P, for PIBDNet—the Pediatric IBD Network for Research and Improvement. Variation in initial 6-mercaptopurine dosage in Crohn disease. J Pediatr Gastroenterol Nutr 2005;41:537